About Arkgen Enterprises Private Limited
Data last updated:
Arkgen Enterprises Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 03 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2005PTC037593. Its GSTIN is 29AACCV1339C1ZJ (Karnataka).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.45 Cr. It was formerly known as Viziphar Biosciences Private Limited. It is led by directors Padiyath Mohammed Akbarali and Hathika Akbarali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹92.67 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹9.89 Lakh (net margin 10.7%) and EBITDA of ₹11.34 Lakh (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
The company has 1 deal on record (1 acquisition); the latest was in August 2013. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Labonno Bio Research Private Limited with revenue of ₹96.32 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vizipharbio.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot #488B Flat # 303 – 304 Vitc Model Export Bhavan 14th Crs IV Phase II Stage Peenya Indu., Area, Bangalore, Karnataka, India – 560058
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Arkgen Enterprises Private Limited
The main business activity of Arkgen Enterprises is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Arkgen Enterprises Private Limited FY 2025 filings available
Arkgen Enterprises Private Limited reported revenue of ₹92.67 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Arkgen Enterprises Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 6% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Arkgen Enterprises Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.34 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.89 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Arkgen Enterprises Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Arkgen Enterprises are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Arkgen Enterprises Private Limited
Arkgen Enterprises Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Its own revenue is ₹92.67 Lakh.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Labonno Bio Research Private Limited | ₹96.32 Lakh | ₹26,352 | 0% | +612% | Krishnagar - I, West Bengal, India | |
| Excelya India Private Limited | ₹95.98 Lakh | ₹10.27 Lakh | 11% | Bangalore North, Karnataka, India | ||
| Somex Research and Health Private Limited | ₹95.52 Lakh | ₹22.62 Lakh | 24% | -66% | Jaipur, Rajasthan, India | |
| Canvass Clinical Research Services Private Limited | ₹93.23 Lakh | ₹14.4 Lakh | 15% | +44% | Nagpur, Maharashtra, India | |
| Cytespace Research Private Limited | ₹93.04 Lakh | ₹1.92 Cr | -207% | -34% | 1 | Ahmedabad, Gujarat, India |
| Arkgen Enterprises Private Limited this company | ₹92.67 Lakh | ₹9.89 Lakh | 10.7% | Bangalore, Karnataka, India | ||
| L1 Laboratories Private Limited | ₹91.59 Lakh | ₹3.9 Lakh | 4% | +656% | Tirumalagiri, Telangana, India | |
| Ursceal Pharma Private Limited | ₹91.19 Lakh | ₹11.31 Lakh | -12% | -20% | Noida, Uttar Pradesh, India | |
| Maven Scientific Laboratories Private Limited | ₹88.95 Lakh | ₹6.2 Lakh | 7% | +25% | Gachibowli, Telangana, India | |
| GPC Lifesciences Private Limited | ₹88.6 Lakh | ₹2.45 Lakh | 3% | +293% | Pune, Maharashtra, India | |
| Indglobl Nextgen Medicare Limited | ₹88.5 Lakh | ₹42,509 | 0% | +53% | Chengalpattu, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Arkgen Enterprises by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Figures are as filed with the Ministry of Corporate Affairs or the stock exchanges.
Auditor Details of Arkgen Enterprises Private Limited
Arkgen Enterprises Private Limited is audited by Raviprasad Thantry K R for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Raviprasad Thantry K R | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Arkgen Enterprises Private Limited
Arkgen Enterprises has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Padiyath Mohammed Akbarali Also directs: Arkgen Pharma Private Limited | Director | 19 May 2016 | 10 Years 4 Months | Current |
| Hathika Akbarali Also directs: Arkgen Pharma Private Limited | Director | 19 May 2016 | 10 Years 4 Months | Current |
Ownership and Shareholding of Arkgen Enterprises Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Arkgen Enterprises Private Limited
Arkgen Enterprises Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Arkgen Enterprises Private Limited
Arkgen Enterprises Private Limited has 1 deal on record (1 acquisition); the latest was in August 2013.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2013 | Acquisition | ₹46 Lakh | Buyer: Laurus Labs Limited Seller: an individual |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Arkgen Enterprises Private Limited
Employment history and EPFO contributions of people linked to Arkgen Enterprises.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Arkgen Enterprises Private Limited
Arkgen Enterprises Private Limited has 9 board changes on record since 2006: 3 appointments and 6 cessations. The latest: Sreenivasa Rao Damarla ceased to be Whole-Time Director on 29 Aug 2016.
Credit Ratings, Litigation & Regulatory Alerts for Arkgen Enterprises Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Arkgen Enterprises Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arkgen Enterprises Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Arkgen Enterprises Private Limited
Arkgen Enterprises has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCV1339C1ZJ | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arkgen Enterprises Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arkgen Enterprises Private Limited
Arkgen Enterprises is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 03 November 2005 (21+ years old) and is registered under CIN U73100KA2005PTC037593.
Arkgen Enterprises reported revenue of ₹92.67 Lakh for FY 2025 (up 6% YoY).
Arkgen Enterprises has 2 current directors:
- Padiyath Mohammed Akbarali - Director
- Hathika Akbarali - Director
Arkgen Enterprises reported a net profit of ₹9.89 Lakh (net margin 10.7%) and EBITDA of ₹11.34 Lakh (EBITDA margin 12.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Arkgen Enterprises is -7% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Arkgen Enterprises is 29AACCV1339C1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Arkgen Enterprises is U73100KA2005PTC037593. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arkgen Enterprises was incorporated on 03 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Bangalore.
Arkgen Enterprises has 1 deal on record (1 acquisition); the latest was in August 2013.
The peers of Arkgen Enterprises by revenue are Labonno Bio Research Private Limited, Excelya India Private Limited, Somex Research and Health Private Limited, Canvass Clinical Research Services Private Limited, Cytespace Research Private Limited and 5 more, all in the Pharma industry (Contract Research).
Sreenivasa Rao Damarla ceased to be Whole-Time Director on 29 Aug 2016. Chandrakanth Chereddi ceased to be Additional Director on 19 May 2016. Hathika Akbarali was appointed as Director on 19 May 2016. Arkgen Enterprises has 9 board changes on record in total.